Die Second-look Operation beim Ovarialkarzinom

1990 ◽  
Vol 30 (1) ◽  
pp. 34-37
Author(s):  
H. Kölbl
Keyword(s):  
Second Look ◽  
Second Look Operation

A second look at the second look operation in colonic cancer after the administration of fluorouracil

1974 ◽  
Vol 128 (6) ◽  
pp. 763-766 ◽  
Author(s):  
S. Mackman ◽  
F.J. Ansfield ◽  
G. Ramirez ◽  
A.R. Curreri
Keyword(s):  
Colonic Cancer ◽  
Second Look ◽  
Second Look Operation

scholarly journals Evaluation of staging, cytoreduction and second-look operation of 119 ovarian cancer patients

1997 ◽  
Vol 115 (5) ◽  
pp. 1542-1547
Author(s):  
Eddie Fernando Candido Murta ◽  
Jurandyr Moreira de Andrade ◽  
Maurício Mesquita Sabino de Freitas ◽  
Sérgio Bighetti
Keyword(s):  
Ovarian Cancer ◽  
Retrospective Study ◽  
Medical Records ◽  
Residual Disease ◽  
School Of Medicine ◽  
Second Look ◽  
Gynecology And Obstetrics ◽  
Data Source ◽  
Level Of Significance ◽  
Second Look Operation

OBJECTIVE:This study was conducted on patients with ovarian cancer in order to evaluate survival. DESIGN: A retrospective study of 119 cases of ovarian cancer from January 1977 to December 1992 with observation until 1993. LOCATION: Department of Gynecology and Obstetrics, Ribeirão Preto School of Medicine, São Paulo University. PARTICIPANTS: Of the 119 cases, 70 (58.8%) presented epithelial carcinomas and 21 (17.6%) tumors of the sexual girdle/stroma. DATA SOURCE: The data were obtained from the medical records of the patients. MEASUREMENT: Statistical analysis of survival time was based on the nonparametric Mann-Whitney test with the level of significance set at P < 0.05. RESULTS: The patients with a negative second look had a mean survival of 79.4 ± 48.5 months versus 24.2 ± 15.1 months for patients with a positive second look (P < 0.02). CONCLUSIONS: It is concluded that patients with a negative second look present a better prognosis compared to those with residual disease.

Relation between CA125 levels and second-look operation for ovarian cancer

1997 ◽  
Author(s):  
H Nishimura ◽  
Y Kiyozuka ◽  
K Imamura ◽  
N Ohkura ◽  
F Murakami ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Second Look ◽  
Second Look Operation

The second-look operation improves survival in suboptimally debulked stage III ovarian cancer patients

2005 ◽  
Vol 15 (1) ◽  
pp. 19-25 ◽  
Author(s):  
J. Rahaman ◽  
P. Dottino ◽  
T. S. Jennings ◽  
J. Holland ◽  
C. J. Cohen
Keyword(s):  
Ovarian Cancer ◽  
Residual Disease ◽  
Stage Iii ◽  
Single Institution ◽  
Primary Ovarian Cancer ◽  
Primary Surgery ◽  
Second Look ◽  
Survival Difference ◽  
Second Look Operation

In a single-institution retrospective cohort study, 230 patients were treated for stage III primary ovarian cancer and 175 became eligible for second-look operations by virtue of a complete clinical response after primary surgical cytoreduction and platinum-based combination chemotherapy. Of these, 109 underwent a second-look operation. Optimal primary cytoreduction was defined as residual disease ≤1 cm. Median follow-up was 68.3 months. Five-year survival for all the 230 stage III ovarian cancers was 43.4%. Among all eligible patients (n = 175), there was no survival difference (P = 0.67) in those having second look (57.3%, 5-year survival) versus no second look (48.7%). In those patients with optimal primary cytoreduction (n = 118), there was no survival advantage to second look (69% versus 61%, P = 0.7). However, in those with suboptimal primary cytoreduction (n = 47), 5-year survival was 36% in those having second look versus only 13% in those refusing second look (P < 0.05). Multivariate analysis identified second-look surgery as the only significant independent prognostic variable affecting survival (RR = 0.321, P < 0.04). Patients with suboptimal debulking at primary surgery for stage III ovarian cancer appear to achieve a survival benefit from second-look surgical procedures, presumably from the early identification and treatment of residual disease.

Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO Stages III and IV) as measured by surgical end-staging (second-look operation)

1983 ◽  
Vol 145 (8) ◽  
pp. 955-967 ◽  
Author(s):  
Carmel J. Cohen ◽  
Judith D. Goldberg ◽  
James F. Holland ◽  
Howard W. Bruckner ◽  
Gunter Deppe ◽  
...  
Keyword(s):  
Ovarian Carcinoma ◽  
Second Look ◽  
Second Look Operation

Does a Second-look Operation Improve Survival in Patients with Peritonitis due to Acute Mesenteric Ischemia? A Five-year Retrospective Experience

2005 ◽  
Vol 29 (5) ◽  
pp. 645-648 ◽  
Author(s):  
Oleg Kaminsky ◽  
Igal Yampolski ◽  
David Aranovich ◽  
Ehud Gnessin ◽  
Franklin Greif
Keyword(s):  
Mesenteric Ischemia ◽  
Acute Mesenteric Ischemia ◽  
Second Look ◽  
Second Look Operation

scholarly journals Second-Look Operation for Unresectable Pancreatic Ductal Adenocarcinoma at a High-Volume Center

2007 ◽  
Vol 15 (1) ◽  
pp. 186-192 ◽  
Author(s):  
Christoph W. Michalski ◽  
Jörg Kleeff ◽  
Jeannine Bachmann ◽  
Jaber AlKhatib ◽  
Mert Erkan ◽  
...  
Keyword(s):  
Pancreatic Ductal Adenocarcinoma ◽  
High Volume ◽  
Ductal Adenocarcinoma ◽  
Second Look ◽  
High Volume Center ◽  
Second Look Operation
Sign in / Sign up

Export Citation Format

Share Document